About.

A neurological condition called Parkinson's disease is characterized by increasingly severe pain. It affects about 1% of seniors 60 years or older in industrialized nations. Reliable Source Experts like Dr. David Greene Arizona believe that inherited and environmental factors may be involved, even if the exact cause of the condition remains unknown. Dopamine levels decrease due to Parkinson's disease-related neuronal death in particular brain areas.

What have clinical trials found?

Before developing the technique for creating iPSCs, the only stem cell therapy for Parkinson's disease involved embryonic stem cells. However, this created moral and practical issues, which made the research process more challenging.

Trials have shown improvement in both movement problems and nonmotor symptoms, such as bladder control. There are various challenges in the stem cell's place of origin. Using stem cells is comparable to transplanting an organ.

However, experts believe that this will delay stem cell therapy while the iPSCs are being developed in the lab. In addition, this will be more expensive than a donor's validated, proven line of iPSCs.